Who owns Etf Ser Solutions loncar cancer?
- Ticker: CNCR
- CUSIP Number: 26922a826
Tip: Access positions for across all investors
Analyze quarterly positions in Etf Ser Solutions loncar cancer with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Etf Ser Solutions loncar cancer stock
Who bought or sold Etf Ser Solutions loncar cancer this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Colony | 31k | $420k | 100% | Dec 2023 |
|
| Royal Bank of Canada | 11k | $153k | 122% | Dec 2023 |
|
| Prospera Financial Services | 10k | $135k | 0% | Dec 2023 |
|
| UBS Group | 1.9k | $25k | -2% | Dec 2023 |
|
| Blue Bell Private Wealth Management | 1.4k | $19k | -17% | Dec 2023 |
|
| SOA Wealth Advisors | 150.00 | $2.5k | 0% | Mar 2024 |
|
| Advisor Group Holdings | 150.00 | $2.0k | -96% | Dec 2023 |
|
Who sold out of Etf Ser Solutions loncar cancer?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vontobel Holding | Sep 2023 | 26k | $283k |
| Jane Street | Sep 2023 | 14k | $151k |
| Private Advisor | Sep 2023 | 10k | $113k |
| Coastal Investment Advisors | Sep 2023 | 539.00 | $7.0k |